The anti-cancer drug administration course (ADAC) supports health professionals to develop the necessary knowledge and clinical skills to administer anti-cancer drugs and safely handle hazardous drugs and related waste.
ADAC provides standardised education for the safe administration of anti-cancer drugs and safe handling of hazardous drugs and related waste.
The course consists of online learning and assessment supported by a clinical skills workshop to consolidate theory to practice. Competency assessments are used to assess clinical skill. There are two exit points in the course, the first at safe handling and the second at administering.
Workbooks have been provided to assist you in applying the principles discussed in the modules to your local work context and role. If you choose to use the workbook, whenever you see a workplace reflection in the module, there is space allocated in the workbook for you to record notes if you wish. Please confirm with your local facilitator if the workbook is mandated at your workplace.
This module provides an overview of the characteristics of hazardous drugs and principles of risk management in the workplace, including the safe handling of hazardous drugs and related waste, and the management of risk and exposure in the workplace.
By accessing this eLearning, you agree to the eviQ Education Disclaimer and Copyright.
This module provides an overview of the common side effects and supportive care measures associated with anti-cancer drug treatment.
This module provides an overview of reviewing anti-cancer protocols and prescriptions before, during and on completion of anti-cancer drug administration.
This module provides an outline of the priorities in providing education to patients receiving anti-cancer drugs and carers administering them in the home environment.
This module provides an overview of patient assessment before, during and on completion of anti-cancer drug administration.
This module provides an overview of administering anti-cancer drugs, including route specific considerations.
The various sections of part 2 of this module are not mandated by all facilities, please confirm with your facilitator which sections of module 7 part 2 are mandated by your facility.
The Paediatric Anti-cancer drug administration course (PADAC) has received formal endorsement from the Australian and New Zealand Children’s Haematology Oncology Group (ANZCHOG) board. The course was developed in collaboration with a paediatric subject matter expert and has been peer reviewed by expert health professionals representing all ANZCHOG sites across Australia and New Zealand. “It is the vision of the ANZCHOG Board that endorsement of PADAC by ANZCHOG will recognise this high quality, well-designed educational resource for the Nursing profession with a focus on improving cancer care for children and adolescents”.
Discuss the principles of safe handling of hazardous drugs and related waste, and the management of risk and exposure in the workplace
Outline the classes and mechanisms of action of anti-cancer drugs
Describe common side effects and supportive care measures associated with anti-cancer drug treatment
Describe the key practice points for reviewing anti-cancer protocols and prescriptions
Discuss key practice points for patient/carer education and education priorities for patients receiving anti-cancer drugs
Discuss key practice points for assessment of patients receiving anti-cancer drugs
Describe the key principles of anti-cancer drug administration and discuss key practice points and recommendations for specific routes of administration
This course is designed for nursing staff administering anti-cancer drugs. Medical and allied health staff may find components of the course useful for their clinical practice.
If you have any questions or would like to provide feedback about this page please submit an enquiry below or visit our FAQ page.